Antiplatelet effects of micronized fenofibrate in subjects with dyslipidemia
نویسندگان
چکیده
منابع مشابه
[Antiplatelet effects of micronized fenofibrate in subjects with dyslipidemia].
INTRODUCTION Fibrates produce additional actions such as reduction of inflammatory state, insulin resistance and activation of blood coagulation, along with stimulation of fibrinolysis. It is not known whether fibrates can attenuate platelet activation. OBJECTIVES Evaluation of antiplatelet effects of fenofibrate in dyslipidemic subjects. PATIENTS AND METHODS In 20 patients (15 males, 5 fem...
متن کاملExtralipid effects of micronized fenofibrate in dyslipidemic patients.
The aim of this study was to evaluate the levels of lipid and extralipid parameters in patients with atherogenic dyslipidemia. We investigated the lipid-lowering therapeutic efficacy of fenofibrate and its extralipid influence on oxidized low-density lipoprotein (oxLDL), C-reactive protein (CRP), Fibrinogen, factor VII and plasminogen activator type 1 (PAI-1) during 1-month treatment. Fourteen ...
متن کاملInhibitory effects of micronized fenofibrate on carotid atherosclerosis in patients with essential hypertension.
BACKGROUND The coexistence of hypertension and dyslipidemia synergistically increases the risk of cardiovascular events. We investigated the effect of the lipid-lowering agent micronized fenofibrate on inhibition of carotid atherosclerosis in patients with essential hypertension and mild hyperlipidemia. METHODS We measured serum lipid profiles and inflammatory markers on chemistry or immune a...
متن کاملHemostatic effects of fenofibrate in patients with mixed dyslipidemia and impaired fasting glucose.
Our study aimed to compare the effect of fenofibrate on hemostasis between patients with isolated impaired fasting glucose (IFG) and isolated mixed dyslipidemia and to examine the action of this agent on glucose and lipid metabolism. Twenty-two IFG and 23 mixed dyslipidemic patients were treated for 90 days with micronized fenofibrate (267 mg/day) and were compared with 22 age-, sex- and weight...
متن کاملMicronized fenofibrate: a new fibric acid hypolipidemic agent.
OBJECTIVE To review the efficacy and safety of fenofibrate in the management of hyperlipidemias. DATA SOURCES A MEDLINE search (1974-October 1998), Current Contents search, additional references from article bibliographies, and the package insert from the manufacturer were used to identify data for evaluation. Studies evaluating fenofibrate (peer-reviewed publications, package insert data) we...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Polish Archives of Internal Medicine
سال: 2007
ISSN: 1897-9483
DOI: 10.20452/pamw.140